Hirsh J - Search Results

1

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M. Levine M, et al. Among authors: hirsh j. N Engl J Med. 1996 Mar 14;334(11):677-81. doi: 10.1056/NEJM199603143341101. N Engl J Med. 1996. PMID: 8594425 Free article. Clinical Trial.

2

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators. Kearon C, et al. Among authors: hirsh j. JAMA. 2006 Aug 23;296(8):935-42. doi: 10.1001/jama.296.8.935. JAMA. 2006. PMID: 16926353 Clinical Trial.

3

Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer.

Hirsh J, Ginsberg JS. Hirsh J, et al. N Engl J Med. 2018 Feb 15;378(7):673-674. doi: 10.1056/NEJMe1800041. N Engl J Med. 2018. PMID: 29443673 No abstract available.

4

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs MJ. Crowther MA, et al. Among authors: hirsh j. N Engl J Med. 2003 Sep 18;349(12):1133-8. doi: 10.1056/NEJMoa035241. N Engl J Med. 2003. PMID: 13679527 Free article. Clinical Trial.

5

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J. Levine MN, et al. Among authors: hirsh j. Ann Intern Med. 1991 Apr 1;114(7):545-51. doi: 10.7326/0003-4819-114-7-545. Ann Intern Med. 1991. PMID: 1848054 Clinical Trial.

6

Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.

Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank M, Jay R, Gent M. Turpie AG, et al. Among authors: hirsh j. Chest. 1990 Apr;97(4 Suppl):172S-175S. Chest. 1990. PMID: 2108855 Clinical Trial.

7

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.

Hull RD, Raskob GE, Rosenbloom D, Panju AA, Brill-Edwards P, Ginsberg JS, Hirsh J, Martin GJ, Green D. Hull RD, et al. Among authors: hirsh j. N Engl J Med. 1990 May 3;322(18):1260-4. doi: 10.1056/NEJM199005033221802. N Engl J Med. 1990. PMID: 2183055 Free article. Clinical Trial.

8

Use of plasminogen activators in venous thrombosis.

Hirsh J, Turpie AG. Hirsh J, et al. World J Surg. 1990 Sep-Oct;14(5):688-93. doi: 10.1007/BF01658826. World J Surg. 1990. PMID: 2238671 Review.

9

Clinical use of low molecular weight heparins and heparinoids.

Levine MN, Hirsh J. Levine MN, et al. Among authors: hirsh j. Semin Thromb Hemost. 1988 Jan;14(1):116-25. doi: 10.1055/s-2007-1002764. Semin Thromb Hemost. 1988. PMID: 2451292 Review. No abstract available.

10

The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement.

Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. Levine MN, et al. Among authors: hirsh j. Thromb Haemost. 1989 Nov 24;62(3):940-4. Thromb Haemost. 1989. PMID: 2556813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters